Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CI-1040 in advanced solid tumors
NCT00034827Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ci-1040 in colorectal cancer (CRC), non-small cell lung cancer (NSCLC), breast cancer, pancreatic cancer (PC), sponsored by Pfizer. Started Jan 2002; status: completed.
02
Drugs
ci-1040
03
Conditions
colorectal cancer (CRC)non-small cell lung cancer (NSCLC)breast cancerpancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00034827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034827.